Books > Science & Mathematics > Biology, life sciences > Biochemistry > Toxicology (non-medical)
|
Buy Now
Pharmaceutical Biocatalysis - Chemoenzymatic Synthesis of Active Pharmaceutical Ingredients (Hardcover)
Loot Price: R11,713
Discovery Miles 117 130
|
|
Pharmaceutical Biocatalysis - Chemoenzymatic Synthesis of Active Pharmaceutical Ingredients (Hardcover)
Expected to ship within 12 - 17 working days
|
This volume provides an insight into the future strategies for
commercial biocatalysis with a focus on sustainable technologies,
together with chemoenzymatic and biotechnological approaches to
synthesize various types of approved and new active pharmaceutical
ingredients (APIs) via proven and latest synthetic routes using
single-step biocatalytic or enzyme cascade reactions. Many of these
drugs act as enzyme inhibitors, as discussed in a chapter with a
variety of examples. The targeted enzymes are involved in diseases
such as different cancers, metastatic and infectious diseases,
osteoporosis, and cardiovascular disorders. The biocatalysts
employed for API synthesis include hydrolytic enzymes, alcohol
dehydrogenases, laccases, imine reductases, reductive aminases,
peroxygenases, cytochrome P450 enzymes, polyketide synthases,
transaminases, and halogenases. Many of them have been improved
with respect to their properties by engineering methods. The book
discusses the syntheses of drugs, including alkaloids and
antibiotics, non-ribosomal peptides, antimalarial and antidiabetic
drugs, prenylated xanthones, antioxidants, and many important
(chiral) intermediates required for the synthesis of
pharmaceuticals.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.